C4B and neoplasm: To identify tumors with robust infiltration of CHIP-derived immune cells, we defined tumor-infiltrating clonal hematopoiesis, or TI-CH, as the presence of CHIP mutations within tumors at a VAF of 2% or more in at least one region.